ORM-12741

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2014-2017
02420142017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
INTRODUCTION ORM-12741 is a novel selective antagonist of alpha-2C adrenoceptors. This trial evaluated the safety and efficacy of… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2017
Review
2017
α2A- and α2C-adrenoceptors (ARs) are the primary α2-AR subtypes involved in central nervous system (CNS) function. These… (More)
Is this relevant?
Review
2017
Review
2017
INTRODUCTION Neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD) are associated with significant negative outcomes for… (More)
Is this relevant?
2017
2017
Treatment of TBI remains a major unmet medical need, with 2.5 million new cases of traumatic brain injury (TBI) each year in… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2014
2014
OBJECTIVES Our primary purpose was to evaluate the efficacy of the high-potency α2C-adrenoceptor antagonist ORM-12741 in the… (More)
  • table 1
  • figure 1
Is this relevant?